Biovest International, Inc. (BVTI.OB) Reports Clinically and Statistically Significant Data from Phase 3 Trial of BiovaxID®
Posted on Saturday, July 19th, 2008 | In Biotech, Current Market News, OTCBB Markets, Small & Micro Cap, Stocks to WatchBiovest International, Inc. (BVTI.OB), a pioneer in the development of advanced individualized immunotherapies for life-threatening cancers of the blood system, and a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc. (NASDAQ:ABPI), recently announced clinically and statistically significant unblinded data from the company’s randomized controlled pivotal Phase 3 fast-tracked clinical trial of BiovaxID®, a treatment for non-Hodgkin’s lymphoma.
BiovaxID® is a personalized, patient-specific therapeutic vaccine designed to stimulate the patient’s own immune system to recognize and destroy cancerous B-cells that may remain in the body after chemotherapy treatment. BiovaxID® is designed to kill only cancerous B-cells for patients diagnosed with non-Hodgkin’s lymphoma, unlike other traditional medical treatments, such as radiation and chemotherapy, which destroy healthy cells and cancerous cells throughout the body. BiovaxID® could potentially be useful in the treatment of other types of B-cell cancers, such as mantle cell lymphoma, chronic lymphocytic leukemia and multiple myeloma.
Originally developed and advanced into human clinical trials by the National Cancer Institute (NCI), the Phase 3 trial for BiovaxID® supported highly encouraging clinical evidence on vaccinated patients regarding efficacy and safety. Biovest International intends to move forward with plans to seek accelerated and/or conditional regulatory approvals in the United States and in Europe.
Let us hear your thoughts below:
Last 5 posts by QualityStocks
- Magellan Petroleum Corp. (MPET) Reports Increase in Second Quarter Net Income - February 8th, 2010
- China Jo-Jo Drugstores Inc. (CJJD.OB) Posts Q3 Increases across the Board - February 8th, 2010
- Fonix Corp. (FNXC.OB) Up 55.56% Following QualityStocks Coverage - February 8th, 2010
- Simulated Environment Concepts, Inc. (SMEV.PK) Led by an Exceptional Executive Trio - February 8th, 2010
- NetSol Technologies, Inc. (NTWK) is an Ideal Solution Provider for Energy and Utilities, Including Green Energy - February 8th, 2010
 About QualityStocks (http://QualityStocks.net)
Our name, QualityStocks, emphasizes our commitment to connect subscribers with companies that have huge potential to succeed in the short and long-term future. We believe strong management and vision for the future are crucial for any company to be successful. Timing is everything and we help investors succeed by providing an objective, broad-based view of the SmallCap markets on a daily basis. Please see disclaimer on QualityStocks website: http://disclaimer.qualitystocks.net |
No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.